Abiopharma

BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine

Clinical trial NCT05285345 updates: 1. status: UNKNOWN → RECRUITING 2. completion date: 2025-11-01 → 2027-11-01 3. primary completion date: 2025-11-01 → 2027-05-01

Clinical trial NCT05445778: primary completion date: 2032-05-01 → 2027-04-01.

Clinical trial NCT06052631: start date: 2026-06-04 → 2026-06-07.

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

Aeropay Announces Integration with Jack Henry to Strengthen Instant Pay by Bank Infrastructure

Karyopharm to Present Results from Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis in Late-Breaking Oral Presentation at ASCO 2026 with Simultaneous Publication in the Journal of Clinical Oncology

Clinical trial NCT07291076: enrollment: 129 → 198 participants.

Clinical trial NCT02856893 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-12-01 → 2025-08-12

Clinical trial NCT07166094 updates: 1. completion date: 2029-02-01 → 2029-11-01 2. primary completion date: 2028-11-01 → 2029-08-01 3. enrollment: 544 → 660 participants